Angiotensin II type 1 receptors and oestrogen status: Interaction or dissociation?

Journal of Hypertension

Volumn 20, Issue 7, 2002, Pages 1267-1269

  Zhuo, Jia L ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ESTRADIOL; ESTROGEN; IRBESARTAN; N(G) NITROARGININE METHYL ESTER; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ANGIOTENSIN RECEPTOR; ANTIHYPERTENSIVE AGENT; BIPHENYL DERIVATIVE; TETRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ATHEROSCLEROSIS; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DISSOCIATION; ESTROGEN DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MOLECULAR INTERACTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SHORT SURVEY; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; NOTE; PHYSIOLOGY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STATISTICS; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BIPHENYL COMPOUNDS; ENDOTHELIUM, VASCULAR; ESTROGENS; HUMANS; RATS; RATS, INBRED SHR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; STATISTICS; TETRAZOLES;

EID: 0036628743     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200207000-00006     Document Type: Short Survey

References (26)

1. Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: A unifying hypothesis
2. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
3. Female sex hormones and cardiovascular disease: Implications for therapy
4. Angiotensin II administration as an experimental model of hypertension
5. Angiotensin receptors and their therapeutic implications
6. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells
7. The time has come to stop letting the HERS tale wag the dogma
8. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
9. Differential regulation of angiotensin peptides in plasma and kidney: Effects of adrenalectomy and estrogen treatment
10. Estrogen regulation of angiotensin-converting enzyme mRNA
11. Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS
12. Effects of chronic hormone replacement on the renin-angiotensin system in cynomolgus monkeys
13. 1 receptor gene expression in vascular smooth muscle cells
14. Estradiol attenuates angiotensin-induced aldosterone secretion in ovariectomized rats
15. 1 receptor binding and mRNA in the female rat
16. The distribution of angiotensin II receptors
17. Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive rats
18. 1 receptor gene expression in vitro and in vivo
19. Chronic estrogen alters contractile responsiveness to angiotensin II and norepinephrine in female rat aorta
20. Low-dose estrogen supplementation improves vascular function in hypogonadal men
21. Angiotensin II type 1 receptor blocker irbesartan ameliorates vascular function in spontaneously hypertensive rats regardless of estrogen status
22. Influence of estrogen on aortic stiffness and endothelial function in female rats
23. Variation in the renin angiotensin system throughout the normal menstrual cycle
24. 1 receptor
25. Endogenous angiotensin II levels and the mechanism of action of angiotensin-converting enzyme inhibitors and angiotensin receptor type 1 antagonists
26. 2 receptor in blood pressure regulation and therapeutic implications